4 Current news of Burrill & Company
rss03-12-2009
New statistics just released reveal that R&D investment in new medicines by the biopharmaceutical industry was $65.2 billion in 2008, an increase of 3 percent from 2007, according to a combined analysis conducted by Burrill & Company and the Pharmaceutical Research and Manufacturers of ...
03-26-2008
New statistics just released reveal that R&D investment in new medicines by the biopharmaceutical industry was $58.8 billion in 2007, according to a combined analysis conducted by Burrill & Company. PhRMA-member (Pharmaceutical Research and Manufacturers of America) companies alone spent an ...
02-15-2007
New statistics just released reveal that R&D investments in new medicines by the biopharmaceutical industry was over $55 billion in 2006, according to a combined analysis conducted by Burrill & Company and the Pharmaceutical Research and Manufacturers of America (PhRMA). "This is the third ...
G. Steven Burrill's 18th Annual Report on the biotech industry's released
03-05-2004
San Francisco. Biotech staged a spectacular comeback in 2003, rekindling enthusiasm on Wall Street and turning in the industry's second best year. 2003 was a year of getting "back on track" for biotech; its market capitalization rose by 53%. A much improved FDA approved some 25 new biotech ...
